SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-20-000353
Filing Date
2020-12-21
Accepted
2020-12-21 14:53:33
Documents
75
Period of Report
2020-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q gnbt103120form10q.htm 10-Q 790937
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11919
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11889
4 EXHIBIT 32 ex32.htm EX-32 3837
5 GRAPHIC image_002.gif GRAPHIC 3785
  Complete submission text file 0001607062-20-000353.txt   4327475

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE gnbt-20201031.xml EX-101.INS 615634
7 XBRL SCHEMA FILE gnbt-20201031.xsd EX-101.SCH 62197
8 XBRL CALCULATION FILE gnbt-20201031_cal.xml EX-101.CAL 58979
9 XBRL DEFINITION FILE gnbt-20201031_def.xml EX-101.DEF 226165
10 XBRL LABEL FILE gnbt-20201031_lab.xml EX-101.LAB 350909
11 XBRL PRESENTATION FILE gnbt-20201031_pre.xml EX-101.PRE 320708
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 201403909
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences